PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Uniphar takeover fails; Pearson notes redemption end

Fri, 16th Dec 2022 21:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Pearson PLC - London-based education publisher - Notes that Pearson Funding completed the redemption of its USD94.2 million principal amount outstanding of its 3.3% guaranteed notes due 2023 at a redemption price of USD1,003. The notes were guaranteed by Pearson PLC.

----------

Bank of Cyprus Holdings PLC - Nicosia-based lender - Extends the appointment of its group chief executive officer Panicos Nicolaou to December 31, 2026. Signs an amending agreement to his existing contract of employment which extends the period.

----------

Technology Minerals PLC - London-based company focused on creating a circular economy for battery metals - Draws down a GBP500,000 tranche from its GBP4.0 million convertible bond facility with Macquarie Bank Ltd and Atlas Capital Markets LLC.

----------

Anpario PLC - manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity - Receives an ISO 14001 certification. It is an internationally recognised standard for Environmental Management Systems. "We are pleased to have been accredited with ISO 14001 as this reflects our team's high operational standards which are focused on achieving our ambitious sustainability goals without negatively impacting our planet," Corporate Responsibility Director Karen Prior comments.

----------

Zanaga Iron Ore Company Ltd - iron ore exploration and development company - Completes the acquisition of a 50% plus one share interest in Jumelles Ltd. Appoints Peter Hill and Denis Weinstein to the board of the company.

----------

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - Enters into a clinical trial collaboration and supply agreement with Merck & Co for the supply of Keytruda, or pembrolizumab, an antibody used in cancer immunotherapy. "We are delighted to enter into a collaboration agreement with MSD for our ongoing PORCUPINE2 study to evaluate RXC004 in combination with their anti-PD-1 therapy, pembrolizumab. Biliary cancer is a devastating disease that is heavily reliant on Wnt signalling, so we are keen to explore the potential of combining RXC004 with ICIs. Our hypothesis, based on the preclinical data we have generated, is that when combined, there may be a greater chance of the patients showing an immune response, which we hope will lead to improved outcomes," Chief Medical Officer Jane Robertson says.

----------

Bushveld Minerals Ltd - South Africa-focused vanadium producer and energy storage provider - Says that Jacqueline Musiitwa will stand down as an Independent Non-Executive Director from the company's board effective immediately.

----------

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers - Gets "encouraging" initial results from an interim analysis conducted for the Refine-ALS prospective trial. It is a prospective, multicenter study sponsored by Mitsubishi Tanabe Pharma America. It is designed to identify biomarkers that could serve as quantifiable, biological and non-clinical measures of Edaravone's pharmacodynamic effect in Amyotrophic Lateral Sclerosis, a progressive nervous system disease.

----------

Uniphar PLC - Dublin-based healthcare business focusing on pharmaceutical and medical technology manufacturers - Reports that the Irish Competition & Consumer Protection Commission has not cleared its proposed acquisition of Dublin-based healthcare services provider Navi Group. States that the transaction will now no longer proceed to completion, as a result. The acquisition was first announced in December 2021.

----------

Beowulf Mining PLC - Natural resource developer and explorer focused on the Nordic region - Says its two new licenses at the Vardar lead-zinc-silver trend in Kosovo extend the coverage of Vardar's Mitrovica and Shala exploration projects. Adds that the two licences contain prospective "carbonate host rocks along with Oligocene magmatic rocks."

"The district being explored in northern Kosovo is highly prospective, with abundant evidence of widespread lead-zinc-silver mineralisation, and the addition of these new licences to Vardar's portfolio is a further exciting development. The Vardar team continues to use state-of-the-art exploration methodologies in the process of identifying new opportunities and is maintaining a competitive first-mover advantage in the region," CEO Kurt Budge says.

----------

PetroNeft Resources PLC - Ireland-based, Russian-focused oil and gas exploration and production company - Says that it is continuing to be in negotiations with Petrogrand AB regarding its loan facility. The facility has a current redemption value of USD2.5 million and matured on Thursday. "We cannot predict the outcome of these negotiations and the company will make further announcements in due course," the company states. In 2020 and 2021, PetroNeft extended its loan facility with Swedish firm Petrogrand AB.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2021 15:51

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

Read more
1 Jun 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 May 2021 16:24

EXECUTIVE CHANGES: Imperial Brands CFO enters; DF Capital chair exits

EXECUTIVE CHANGES: Imperial Brands CFO enters; DF Capital chair exits

Read more
5 May 2021 16:37

IN BRIEF: Redx Pharma hires New York-based chief financial officer

IN BRIEF: Redx Pharma hires New York-based chief financial officer

Read more
28 Apr 2021 19:19

IN BRIEF: Redx Pharma starts dosing of first patient cohort of RXC004

IN BRIEF: Redx Pharma starts dosing of first patient cohort of RXC004

Read more
2 Mar 2021 21:39

TRADING UPDATES: Chariot expects gas in Morocco; Redx wants CFO in US

TRADING UPDATES: Chariot expects gas in Morocco; Redx wants CFO in US

Read more
23 Feb 2021 16:16

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
27 Jan 2021 14:06

IN BRIEF: Redx Pharma Full-Year Revenue Increases But Loss Widens

IN BRIEF: Redx Pharma Full-Year Revenue Increases But Loss Widens

Read more
20 Jan 2021 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
23 Dec 2020 15:52

Director dealings: Redx CEO ups stake

(Sharecast News) - Redx Pharma revealed on Wednesday that chief executive Lisa Anson had acquired 39,998 ordinary shares in the AIM-listed drug discovery and development group.

Read more
23 Dec 2020 14:50

UK DIRECTOR DEALINGS SUMMARY: San Leon Energy CEO Cancels Share Buy

UK DIRECTOR DEALINGS SUMMARY: San Leon Energy CEO Cancels Share Buy

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
2 Dec 2020 17:39

IN BRIEF: Redx Pharma Conditionally Raises GBP25.5 Million Via Placing

IN BRIEF: Redx Pharma Conditionally Raises GBP25.5 Million Via Placing

Read more
27 Oct 2020 15:16

IN BRIEF: Redx Pharma Hires New Chief Medical Officer From Achilles

IN BRIEF: Redx Pharma Hires New Chief Medical Officer From Achilles

Read more
9 Sep 2020 13:33

IN BRIEF: Redx Pharma Teams With Jazz To Develop Cancer Therapies

IN BRIEF: Redx Pharma Teams With Jazz To Develop Cancer Therapies

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.